Thomas Martin

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha et al. · Nature Biotechnology · 2022 · 206 citations · Full text

Primary Cells, Genome Instability, High-yield Genome Engineering +11

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Thierry Façon, Meletios Α. Dimopoulos, Xavier P Leleu et al. · New England Journal of Medicine · 2024 · 198 citations

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Sarah A. Holstein, Sin‐Ho Jung, Paul G. Richardson et al. · The Lancet Haematology · 2017 · 168 citations · Full text

Hematological Malignancy, Oncology, Marrow Transplantation +10

TOX-ACLS: Toxicologic-oriented advanced cardiac life support

Timothy E. Albertson, Andrew Dawson, Francisco de Latorre et al. · Annals of Emergency Medicine · 2001 · 154 citations

Translational Medicine, Heart Failure, Cardiovascular Disease +4